Antibody-drug Conjugate Information
General Information of This Antibody-drug Conjugate (ADC)
| ADC ID |
DRG0EXLKR
|
|||||
|---|---|---|---|---|---|---|
| ADC Name |
AB185-ADL14-D1
|
|||||
| Synonyms |
AB185-ADL14-D1
Click to Show/Hide
|
|||||
| Organization |
EISAI R&D MANAGEMENT CO., LTD.
|
|||||
| Drug Status |
Investigative
|
|||||
| Drug-to-Antibody Ratio |
3.5
|
|||||
| Structure |
|
|||||
| Antibody Name |
Trastuzumab
|
Antibody Info | ||||
| Antigen Name |
Receptor tyrosine-protein kinase erbB-2 (ERBB2)
|
Antigen Info | ||||
| Payload Name |
D14 payload
|
Payload Info | ||||
| Linker Name |
Mal-CH2CH2- linker
|
Linker Info | ||||
| Conjugate Type |
Cysteine-maleimide conjugation
|
|||||
| Combination Type |
ADL14-D1
|
|||||